ArticleMethods in molecular biology (Clifton, N.J.)2025
An Integrated High-Throughput Proteocistromic Framework for Mapping the Interactome and Targetome of Human Transcription Factors.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcription factors (TFs) are the main regulators of gene expression, controlling diverse cellular processes such as development, differentiation, and disease progression. A comprehensive analysis of their interactomes and targetomes provides valuable insights into their functions, regulatory mechanisms, and context-dependent roles. This chapter presents a robust methodological framework for investigating the interactome and targetome of TFs, applicable to a wide range of TF families. This workflow integrates advanced proteomic approaches-affinity purification mass spectrometry (AP-MS) and proximity-dependent biotinylation (BioID)-with the cistromic method, chromatin immunoprecipitation sequencing (ChIP-Seq), to identify both stable and transient protein-protein interactions (PPIs) and to identify interactions with DNA (e.g., DNA-binding targets of TFs). The workflow involves the generation of inducible cell lines expressing each TF under study and performing three parallel proteocistromic experiments (AP-MS, BioID, and ChIP-Seq) along with data analysis for network visualization and functional annotation. The workflow is adaptable to various TF families and experimental contexts, offering a versatile platform for uncovering the dynamic regulatory networks that TFs mediate, on both medium and large scales. This workflow advances our ability to comprehensively characterize TF functions, facilitating a deeper understanding of gene regulation and its implications in both health and disease.
Indexed as
Identifiers
40638054What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.